The two drugs, antimalarial therapy proguanil and rheumatoid arthritis medication sulfasalazine, showed they could safety inhibit the replication of the SARS-CoV-2 coronavirus behind COVID-19 in both ...
Sulfasalazine is an anti- inflammatory medication consisting of a combination of 5-aminosalicylic acid and the sulphonamide sulfapyridine. Sulfasalazine has also been used for some skin conditions.
A 5-aminosalicylic acid (5-ASA) drug switch program switching from 5-ASA to sulfasalazine was instituted for insured patients with ulcerative colitis. Unanticipated barriers limited the number of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback